These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1436390)

  • 1. Desensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT.
    Kreiss DS; Lucki I
    Neuropharmacology; 1992 Oct; 31(10):1073-6. PubMed ID: 1436390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nuclei.
    Kreiss DS; Lucki I
    Synapse; 1997 Feb; 25(2):107-16. PubMed ID: 9021891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM; Vilaró MT; Mengod G; Artigas F
    J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
    Nakai K; Fujii T; Fujimoto K; Suzuki T; Kawashima K
    Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei.
    Kreiss DS; Lucki I
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1268-79. PubMed ID: 8014870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study.
    Hjorth S; Sharp T; Liu Y
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):149-57. PubMed ID: 1692973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
    Sugimoto Y; Kimura I; Watanabe Y; Yamada J
    Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo.
    Yoshitake T; Yoshitake S; Yamaguchi M; Ogren SO; Kehr J
    Neuropharmacology; 2003 Feb; 44(2):206-13. PubMed ID: 12623219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5-HT(1A) receptor agonist, 8-OH-DPAT, attenuates stress-induced anorexia in conjunction with the suppression of hypothalamic serotonin release in rats.
    Shimizu N; Hori T; Ogino C; Kawanishi T; Hayashi Y
    Brain Res; 2000 Dec; 887(1):178-82. PubMed ID: 11134602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.
    Hedlund PB; Kelly L; Mazur C; Lovenberg T; Sutcliffe JG; Bonaventure P
    Eur J Pharmacol; 2004 Mar; 487(1-3):125-32. PubMed ID: 15033384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study.
    Gur E; Lerer B; Newman ME
    J Neural Transm (Vienna); 1997; 104(8-9):795-804. PubMed ID: 9451712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study.
    Hadrava V; Blier P; Dennis T; Ortemann C; de Montigny C
    Neuropharmacology; 1995 Oct; 34(10):1311-26. PubMed ID: 8570029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.
    Carli M; Samanin R
    Psychopharmacology (Berl); 2000 Apr; 149(3):259-68. PubMed ID: 10823407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis.
    Hjorth S; Auerbach SB
    Neuropharmacology; 1994; 33(3-4):331-4. PubMed ID: 7984270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.